Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Chromogranin A Polyclonal Antibody Host Rabbit

SKU: E-AB-40339-200

  • $ 54295
  • Save $ 3800


Request a Quote

Chromogranin A Polyclonal Antibody Host Rabbit

 

SKU # E-AB-40339
Reactivity Human, Mouse
Host Rabbit
Applications WB, IHC

 

Product Details

Isotype IgG
Host Rabbit
Reactivity Human, Mouse
Applications WB, IHC
Clonality Polyclonal
Immunogen Recombinant Mouse Chromogranin-A protein
Abbre Chromogranin A
Synonyms CHG A,  CMGA,  CgA,  Chga,  Chromogranin A,  Chromogranin A parathyroid secretory protein 1,  Chromogranin A precursor,  ChromograninA,  ER-37,  Pancreastatin,  Parastatin,  Parathyroid secr,  beta Granin,  betagranin (N-terminal fragment of chromogranin A),  catestatin,  chromofungin
Swissprot
Calculated MW 51 kDa
Observed MW 51 kDa
Cellular Localization Cytoplasmic vesicle, Membrane, Secreted.
Concentration 1 mg/mL
Buffer PBS with 0.05% proclin 300, 1% protective protein and 50% glycerol,pH7.4
Purification Method Antigen Affinity Purification
Research Areas Cancer,  Neuroscience,  Signal Transduction,  Tags and Cell Markers
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.

 

Related Reagents

Applications Recommended Dilution
WB 1:500-1:1000
IHC 1:100-1:300

 

Background

Chromogranin A is a member of the granin family of neuroendocrine secretory proteins. It is located in secretory vesicles of neurons and endocrine cells. Chromogranin A is the precursor to several functional peptides including vasostatin, pancreastatin, catestatin and parastatin. These peptides negatively modulate the neuroendocrine function of the releasing cell (autocrine) or nearby cells (paracrine). CgA is one of the most used tumor markers in NET's (neuroendocrine tumors) ,and elevated CgA concentrations have been demonstrated in serum or plasma of patients with different types of these tumors.